Role of Simvastatin Niacin ER in Cardiac Anomaly Management The integration of Simvastatin Niacin ER into cardiac anomaly management has emerged as a noteworthy advancement in addressing the complexities of Ebstein Anomaly. This congenital heart defect, characterized by the malformation of the tricuspid valve and right heart chambers, poses significant challenges in clinical management. Traditional…
Read More